Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
Study finds 1 in 8 patients with cancer harbour inherited genetic mutations
Genetic testing can uncover inherited genetic mutations, and could individualise cancer therapies, improve survival, manage…
Every month delayed in cancer treatment can raise risk of death by around 10%
People whose treatment for cancer is delayed by even one month have in many cases…
The Oncology Journal Club Episode 15: ESMO Special 3
Today’s episode of The Oncology Journal Club is the third of our ESMO Special Episodes…
Research shows exercise is a boon for cancer patients
Exercise and/or psychological therapy work better than medications to reduce cancer-related fatigue and should be recommended first to patients, according…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.